SFCM
PLRX icon

Seven Fleet Capital Management’s Pliant Therapeutics PLRX Stock Holding History

Seven Fleet Capital Management’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-276,500
Closed -$337K – 130
2025
Q4 		$337K Buy
+276,500
New +$415K 0.23% 55

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Seven Fleet Capital Management's PLRX Position: Q1 2026 in Review

Seven Fleet Capital Management sold out of Pliant Therapeutics (PLRX) in Q1 2026, closing a stake of 276,500 shares — an estimated $337K sold.

Seven Fleet Capital Management first reported a position in PLRX in Q4 2025 and held it in 1 quarter. The position peaked at $337K in Q4 2025. 91 funds tracked by Wall St. Rank hold PLRX as of Q1 2026.

  • Seven Fleet Capital Management reported no remaining Pliant Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Seven Fleet Capital Management sold 276,500 Pliant Therapeutics shares in Q1 2026, an estimated $337K.
  • Seven Fleet Capital Management first reported a position in Pliant Therapeutics in Q4 2025 and held it in 1 quarter.
  • Seven Fleet Capital Management's Pliant Therapeutics position peaked at $337K in Q4 2025.
  • 91 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2026.

Based on Seven Fleet Capital Management's 13F filing for Q1 2026, filed 15 May 2026.